))
Julio Ribeiro: Inventia Life Science
アーカイブされたシリーズ ("無効なフィード" status)
When?
This feed was archived on April 28, 2021 01:13 (
Why? 無効なフィード status. サーバーは持続期間に有効なポッドキャストのフィードを取得することができませんでした。
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 264571512 series 2526422
コンテンツは Mentored.com.au によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Mentored.com.au またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作権で保護された作品をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Julio Ribeiro is the co-founder and CEO of Inventia Life Science, the med-tech company behind the 3D bioprinter technology that creates realistic replicas of tumours to test cancer treatments. Julio grew up in Brazil where he studied biology and genetics, and in the 90’s he migrated to Australia to do his PhD in medicine. After working for a scientific tech supply company, he saw a gap in the market and knew that the science field had the potential to make life a lot better, so he started his company, Inventia Life Science. They developed the bioprinting platform ‘Rastrum’ to print 3D cell models in high quantity with a gel that mimics human tissue, enabling medical researchers to do higher quality experiments into cancer treatment, and potentially also the coronavirus. I ask Julio how he sees biology, computer science and engineering coming together in the next few years and where the highly disruptive sector of 3D printing has the potential to go.
See omnystudio.com/listener for privacy information.
See omnystudio.com/listener for privacy information.
253 つのエピソード
シェア
